168 related articles for article (PubMed ID: 7878293)
21. Management of acute hypercalcemia.
Bilezikian JP
N Engl J Med; 1992 Apr; 326(18):1196-203. PubMed ID: 1532633
[No Abstract] [Full Text] [Related]
22. Newer agents for the treatment of malignant hypercalcemia.
Kinirons MT
Am J Med Sci; 1993 Jun; 305(6):403-6. PubMed ID: 8506902
[TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.
Cvitkovic F; Armand JP; Tubiana-Hulin M; Rossi JF; Warrell RP
Cancer J; 2006; 12(1):47-53. PubMed ID: 16613662
[TBL] [Abstract][Full Text] [Related]
24. Hypercalcemia: Pathophysiology, Clinical Signs, and Emergent Treatment.
Daniels E; Sakakeeny C
J Am Anim Hosp Assoc; 2015; 51(5):291-9. PubMed ID: 26355578
[TBL] [Abstract][Full Text] [Related]
25. Therapy of malignancy-associated hypercalcemia: 1983.
Stewart AF
Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
[TBL] [Abstract][Full Text] [Related]
26. Salmon calcitonin in the acute management of hypercalcemia.
Wisneski LA
Calcif Tissue Int; 1990; 46 Suppl():S26-30. PubMed ID: 2137363
[TBL] [Abstract][Full Text] [Related]
27. Hypercalcaemia due to malignancy. Role of the kidney and treatment.
Sleeboom HP; Bijvoet OL
Contrib Nephrol; 1982; 33():178-96. PubMed ID: 6214375
[No Abstract] [Full Text] [Related]
28. [Malignancy-associated hypercalcemia].
Oura S
Nihon Rinsho; 2003 Jun; 61(6):1006-9. PubMed ID: 12806951
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of intravenous dichloromethylene diphosphonate in paraneoplastic hypercalcemia resistant to mithramycin].
Peyron R; Sereni D; Grateau G; Boissonnas A; Cremer GA; Laroche C
Rev Rhum Mal Osteoartic; 1984; 51(7-8):435-7. PubMed ID: 6238399
[No Abstract] [Full Text] [Related]
30. Clinical trials of gallium nitrate in patients with cancer-related hypercalcemia.
Warrell RP
Semin Oncol; 1991 Aug; 18(4 Suppl 5):26-31. PubMed ID: 1925627
[No Abstract] [Full Text] [Related]
31. Recovery from extreme hypercalcaemia.
Warrell RP; Crown JP
Lancet; 1993 Aug; 342(8867):375. PubMed ID: 8101620
[No Abstract] [Full Text] [Related]
32. Hypercalcemia and gallium nitrate.
Gucalp R
J Support Oncol; 2004; 2(6):518-20. PubMed ID: 16329218
[No Abstract] [Full Text] [Related]
33. [Etiology and therapy of hypercalcemia].
Fujita T
Nihon Rinsho; 1992 Jan; 50 Suppl():404-9. PubMed ID: 1533694
[No Abstract] [Full Text] [Related]
34. Diagnosis and management of hypercalcemia.
Kukreja SC
Compr Ther; 1980 Aug; 6(8):33-8. PubMed ID: 6447571
[No Abstract] [Full Text] [Related]
35. Modern management of malignant hypercalcemia.
Legrand SB
Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
[TBL] [Abstract][Full Text] [Related]
36. Hypercalcemia: diagnosis and therapy.
Canalis EM; Mundy GR; Raisz LG
Conn Med; 1977 Jan; 41(1):16-21. PubMed ID: 137799
[No Abstract] [Full Text] [Related]
37. Symptomatic hypocalcemia following combined calcitonin and mithramycin therapy for hypercalcemia due to malignancy.
Caro JF; Besarab A; Glennon JA
Cancer Treat Rep; 1978 Oct; 62(10):1561-3. PubMed ID: 152145
[TBL] [Abstract][Full Text] [Related]
38. Comparative tolerability of drug therapies for hypercalcaemia of malignancy.
Zojer N; Keck AV; Pecherstorfer M
Drug Saf; 1999 Nov; 21(5):389-406. PubMed ID: 10554053
[TBL] [Abstract][Full Text] [Related]
39. Treatment of bisphosphonate-resistant hypercalcemia of malignancy with calcitonin.
Dawson C; Todd AM; Walton A
J Palliat Med; 2014 Oct; 17(10):1084. PubMed ID: 25265187
[No Abstract] [Full Text] [Related]
40. Medical management of the hypercalcemia of malignancy.
Deftos LJ; Neer R
Annu Rev Med; 1974; 25(0):323-31. PubMed ID: 4277568
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
